A biotech startup launches with unusual goal: invent new drugs, and sell them for less

Share

EQRx, led by veteran biotech venture capitalist Alexis Borisy, is committed to inventing and introducing new drugs at “radically different” prices than what brand-name drugmakers charge. Backed by $200M in initial funding, Borisy aims to develop “equally as good, or better” versions of drugs already on the market and then sell them at sharply lower prices.

Read the full article at biopharmadive.com…

Share

Comments are closed.